Resources
Related Tags:
DepoMed Inc. (14 results)
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Sandvik AB acquires German engineering company DEPO
- NORDIC BUSINESS REPORT-30 September 2004-Sandvik AB acquires German engineering company DEPOC1994-2004 M2 COMMUNICATIONS LTD http://www.m2.com The Swedish high-tech engineering group Sandvik AB said on Thursday (30 September) that it had agreed to acquire the German engineering company DEPO for an undisclosed sum. DEPO provides complete solutions for production...
- Research articles 2004-09-30
Additional Resources
- ATI's Radeon'R' 9800 SE Graphics Processor Selected for New Line of DEPO Ego 360 PCs
- MARKHAM, Ontario -- ATI Technologies Inc. (NASDAQ:ATYT) (TSX:ATY), the global leader for PC graphics, today announced that its RadeonR 9800 SE graphics processors have been selected to power a new line of high-performance multimedia PCs by DEPO Computers, Russia's largest manufacturer of PC systems. DEPO Ego 360 PCs powered by...
- Research articles 2005-04-14
- Second Life as a Business Environment Gains Pace as depo consulting win Four New Deals in two Days.
- MILTON KEYNES, England, June 27 /PRNewswire/ -- depo consulting ltd, a registered full-service Second Life developer, have had their best week ever as they won four new contracts to provide offices in their business park in Second Life. City base MILTON KEYNES,...
- Research articles 2007-06-27
- Daily Market Movers Digest Report for Thursday July 12th, CIPH, DEPO, EFSF, TGEI, NPLA.
- M2 PRESSWIRE-12 July 2007-OTCPicks.com: Daily Market Movers Digest Report for Thursday July 12th, CIPH, DEPO, EFSF, TGEI, NPLAC1994-2007 M2 COMMUNICATIONS LTD RDATE:12072007 Our Stocks to Watch today include Ciphergen Biosystems (NASD: CIPH), DepoMed Inc (NASD: DEPO), eFoodSafety.com (OTCBB: EFSF), Tiger ...
- Research articles 2007-07-12
- Money talks with Consolidated American: CDMJ, PCAP, RYG, DEPO.
- M2 PRESSWIRE-29 July 2005-InvestSource Inc.: Money talks with Consolidated American: CDMJ, PCAP, RYG, DEPOC1994-2005 M2 COMMUNICATIONS LTD RDATE:29072005 Stocks in the News: Consolidated American Industries Corporation (OTC: CDMJ), Patriot Capital Funding (Nasdaq: PCAP), Royal Group Technologies Limited (NYSE: RYG), and...
- Research articles 2005-07-29
- BWR Issues Morning Alerts for Shareholders of NTRI, DEPO, ANSI and DRIV
- The Bellwether Report is the leading online financial newsletter, focusing on small-cap emerging growth opportunities. We strive to introduce investors to truly undervalued opportunities in a time-friendly fashion, allowing for optimal entry points and profitable exit points. Today, BWR will be evaluating the morning's four most promising companies on...
- Research articles 2005-07-28
- Speak with other shareholders about: (NASDAQ: DEPO), (NYSE: THC), (NASDAQ: BMET), and (NYSE: MRK) .
- M2 PRESSWIRE-11 July 2007-Stockwire.com: Speak with other shareholders about: (NASDAQ: DEPO), (NYSE: THC), (NASDAQ: BMET), and (NYSE: MRK) .C1994-2007 M2 COMMUNICATIONS LTD RDATE:11072007 AUSTIN, TX - Are you looking to speak with other investors about your favorite stock? Stockwire.com, ranked in...
- Research articles 2007-07-11
- Stocks to Watch - TGEN, QCOM, CALP, DEPO.
- M2 PRESSWIRE-12 December 2006-SmallCapReview: Stocks to Watch - TGEN, QCOM, CALP, DEPOC1994-2006 M2 COMMUNICATIONS LTD RDATE:12122006 To learn more about featuring your company on SmallCapReview, email editor@smallcapreview.com. Targeted Genetics (Nasdaq: TGEN) Closed at $6.23. Announced that the company...
- Research articles 2006-12-12
- Neurocrine Biosciences Inc. Q2 2008 Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions. It looks like first we'll go to the side of Thomas Wei from Piper Jaffray. Please go ahead. Thomas Wei - Piper Jaffray Thanks very much. I had a couple of questions on the 603 study for elagolix. In listening to your commentary, it sounds...
- Earnings calls 2008-07-30
- Quest for brands: Home Depot Expo builds on names.
- National brands play a prominent role in Home Depo Expo's home furnishings marketing strategy, but getting those brands hasn't been easy. Many vendors are still too focused on conventional distribution channels to do business with a home improvement emporNational brands play a prominent role in Home Depo Expo's home furnishings...
- Research articles 1995-06-12
- Depomed, Biovail Revise Partnership Agreement for Development, Commercialization of Glumetza-tm-; Depomed to Have Rights for United States; Biovail to Have Rights for Canada.
- MENLO PARK, Calif. and TORONTO, Dec 13, 2005 CCNMatthews via COMTEX -- Depomed, Inc. (NASDAQ:DEPO) of Menlo Park, California, and Biovail Corporation (NYSE:BVF)(TSX:BVF) of Canada today announced that the companies have reached a definitive agreeme MENLO PARK, Calif. and TORONTO, Dec 13, 2005 (CCNMatthews via ...
- Research articles 2005-12-13
- ATI's Radeon'R' graphics processors selected by Russia's largest PC manufacturer for top-to-bottom PC lineup.
- MOSCOW, RUSSIA, Jun 16, 2006 CCNMatthews via COMTEX -- ATI GPUs will appear in all back- to-school home and multimedia PCs from DEPO Computers MOSCOW, RUSSIA, Jun 16, 2006 CCNMatthews via COMTEX -- ATI GPUs will appear in all back- to-school home and multimedia...
- Research articles 2006-06-16
- PFIZER INC - Regulatory Approval.
- FDA Approves Pfizer's Depo-subQ provera 104TM for Management of Endometriosis Pain ...
- Research articles 2005-03-29
- Biovail and Depomed Submit NDA for Glumetza; Submission Includes 500mg and 1000mg dosages; Biovail/Depomed Expand Royalty Agreement to Include 1000mg dose.
- TORONTO, Canada & MENLO PARK, Calif., Apr 28, 2004 CCNMatthews via COMTEX -- Biovail Corporation (NYSE:BVF)(TSX:BVF) and Depomed, Inc. (Nasdaq:DEPO) announced today that they had submitted a New Drug Application NDA to the U.S. Food and Drug TORONTO, Canada & MENLO PARK, Calif., Apr 28,...
- Research articles 2004-04-28
- Depomed to Present at Needham & Company, LLC's Fifth Annual Biotechnology and Medical Technology Conference
- MENLO PARK, Calif. -- Depomed, Inc. (NASDAQ:DEPO) today announced that chairman, president and chief executive officer, John W. Fara, Ph.D., will present on Wednesday, June 14, 2006 at 11:30 a.m. Eastern time during the Needham & Company Fifth Annual Biotechnology and Medical Technology Conference to be held in New York....
- Research articles 2006-06-02
- Depomed Submits New Drug Application to FDA for Proquin XR — Ciprofloxacin GR
- MENLO PARK, Calif. -- Depomed, Inc. (Nasdaq:DEPO) today announced that it has submitted a New Drug Application NDA to the U.S. Food and Drug Administration FDA for ProquinTM XR , a once daily, extended release formulation of the antibiotic ciprofloxacin. The company is seeking marketing approval for the treatment of...
- Research articles 2004-07-20
- Depomed Receives $25 Million from Biovail
- MENLO PARK, Calif. -- Depomed, Inc. (Nasdaq:DEPO) announced today that it has received a $25 million milestone payment from Biovail Corporation based on the U.S. Food and Drug Administration approval of GlumetzaTM, once-daily extended release metformin, for the treatment of Type II diabetes.
- Research articles 2005-07-06
- Depomed to Present at the UBS Global Life Sciences Conference
- MENLO PARK, Calif. -- Depomed, Inc. (Nasdaq:DEPO) today announced that chairman, president and chief executive officer, John W. Fara, Ph.D., will present on Wednesday, September 29, 2004 at 10:30 a.m. Eastern Time during the UBS Global Life Sciences Conference to be held in New York.
- Research articles 2004-09-22
- Depomed Files Prior Approval Supplement for 1000 mg Strength Tablets of Glumetza
- MENLO PARK, Calif. -- Depomed, Inc. (NASDAQ:DEPO) announced today that it has filed a prior approval supplement with the U.S. Food and Drug Administration FDA seeking approval to market in the United States 1000 mg strength tablets of GlumetzaTMmetformin hydrochloride extended release tablets. The company expects the FDA to make...
- Research articles 2007-04-02
- Biovail, Depomed Announce Regulatory Approval of Glumetza to Treat Type II Diabetes in Canada
- TORONTO and MENLO PARK, Calif. -- Biovail Corporation (NYSE:BVF) (TSX:BVF) and Depomed, Inc. (Nasdaq:DEPO) announced today that the Therapeutic Products Directorate Canada TPD has issued a Notice of Compliance for 500mg and 1,000mg GlumetzaTM, a once-daily, extended-release formulation of metformin hydrochloride HCl for the treatment of Type II diabetes.
- Research articles 2005-06-01
- << Previous
- page 1 of 1
- Next >>
Presented by American Express